Elequin Capital LP Esperion Therapeutics, Inc. Transaction History

Elequin Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $0 - $3	-1 Reduced 10.0%	9 $0
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $288 - $537	-300 Reduced 96.77%	10 $0
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $372 - $545	310 New	310 $0
Q2 2022 Aug 11, 2022	SELL	$4.77 - $6.67 $38 - $53	-8 Reduced 18.18%	36 $0
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $146 - $244	44 New	44 $0

217

127M

1.61M

1.1M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

Stay updated on Elequin Capital LP with notifications on news.